A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients
- PMID: 19131662
- PMCID: PMC2757095
- DOI: 10.1161/STROKEAHA.108.524587
A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients
Abstract
Background and purpose: Ischemic stroke is a multifactorial disease with a strong genetic component. Pathways, including lipid metabolism, systemic chronic inflammation, coagulation, blood pressure regulation, and cellular adhesion, have been implicated in stroke pathophysiology, and candidate gene polymorphisms in these pathways have been proposed as genetic risk factors.
Methods: We genotyped 105 simple deletions and single nucleotide polymorphisms from 64 candidate genes in 3550 patients and 6560 control subjects from 6 case-control association studies conducted in the United States, Europe, and China. Genotyping was performed using the same immobilized probe typing system and meta-analyses were based on summary logistic regressions for each study. The primary analyses were fixed-effects meta-analyses adjusting for age and sex with additive, dominant, and recessive models of inheritance.
Results: Although 7 polymorphisms showed a nominal additive association, none remained statistically significant after adjustment for multiple comparisons. In contrast, after stratification for hypertension, 2 lymphotoxin-alpha polymorphisms, which are in strong linkage disequilibrium, were significantly associated among nonhypertensive individuals: LTA 252A>G (additive model; OR, 1.41 with 95% CI, 1.20 to 1.65; P=0.00002) and LTA 26Thr>Asn (OR, 1.19 with 95% CI, 1.06 to 1.34; P=0.003). LTA 252A>G remained significant after adjustment for multiple testing using either the false discovery rate or by permutation testing. The 2 single nucleotide polymorphisms showed no association in hypertensive subjects (eg, LTA 252A>G, OR, 0.93; 95% CI, 0.84 to 1.03; P=0.17).
Conclusions: These observations may indicate an important role of LTA-mediated inflammatory processes in the pathogenesis of ischemic stroke.
Figures
References
-
- Rohr J, Kittner S, Feeser B, Hebel JR, Whyte MG, Weinstein A, Kanarak N, Buchholz D, Earley C, Johnson C, Macko R, Price T, Sloan M, Stern B, Wityk R, Wozniak M, Sherwin R. Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol. 1996;53:603–607. - PubMed
-
- Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke. 2003;34:2091–2096. - PubMed
-
- Brophy VH, Ro SK, Rhees BK, Lui LY, Lee JM, Umblas N, Bentley LG, Li J, Cheng S, Browner WS, Erlich HA. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status. Stroke. 2006;37:1385–1390. - PubMed
-
- Zee RY, Brophy VH, Cheng S, Hegener HH, Erlich HA, Ridker PM. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation. Stroke. 2006;37:2012–2017. - PubMed
-
- Zhao Y, Ma LY, Liu YX, Wang XY, Liu LS, Lindpaintner K. [Relationship between alpha-ENaC gene Thr663Ala polymorphism and ischemic stroke] Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001;23:499–501. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AR035583/AR/NIAMS NIH HHS/United States
- AR35582/AR/NIAMS NIH HHS/United States
- R01 AR035584/AR/NIAMS NIH HHS/United States
- AG05394/AG/NIA NIH HHS/United States
- R01 AG027576/AG/NIA NIH HHS/United States
- 2 R01 AG027574-22A1/AG/NIA NIH HHS/United States
- R01 AG005407/AG/NIA NIH HHS/United States
- R01 AR035582/AR/NIAMS NIH HHS/United States
- R01 AG005394/AG/NIA NIH HHS/United States
- AR35584/AR/NIAMS NIH HHS/United States
- R01 HL063293/HL/NHLBI NIH HHS/United States
- R01 HL058755/HL/NHLBI NIH HHS/United States
- R01 AG027574/AG/NIA NIH HHS/United States
- 2 R01 AG005394-22A1/AG/NIA NIH HHS/United States
- AG05407/AG/NIA NIH HHS/United States
- HL-58755/HL/NHLBI NIH HHS/United States
- HL-63293/HL/NHLBI NIH HHS/United States
- R01 AG027576-22/AG/NIA NIH HHS/United States
- AR35583/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
